Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Citius Pharmaceuticals, Inc.

NASDAQ: CTXRHealthcare / Biotechnology / -
1.08-0.07-6.09%Vol 27 4081Y Perf -78.12%
Dec 10th, 2018 11:40
BID1.08 ASK1.10
Open1.14 Previous Close1.15
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.50 
Analyst Rating
Strong Buy 1.00
Potencial %
872.22 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)17 
Earnings Rating
Price Range Ratio 52wk %
0.00 
Earnings Date
-

Today's Price Range

1.081.22

 

52wk Range

1.085.29

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-15.44%
3 Months
-23.33%
6 Months
-57.25%
1 Year
-78.12%
3 Years
-95.21%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CTXR1.08-0.0700-6.09
AAPL165.05-3.4400-2.04
GOOG1 035.56-1.0200-0.10
MSFT104.990.17000.16
XOM75.18-2.4600-3.17
WFC48.62-1.6400-3.26
JNJ143.07-2.3600-1.62
FB140.733.31002.41
GE6.86-0.1500-2.14
JPM100.15-3.1400-3.04
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.30
Current Ratio
1.30
Long Term Debt to Total Capital
-
Total Debt to Equity
0.01
Interest Coverage
-15.00
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.09
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.90
Cash Flow Per Share
-1.35
Price to Tangible Book
36.47
Book Value per Share
1.34
Enterprise Value (in ths.)
21 061
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-87.41
ROE last 12 Months
-76.64
Return on Assets (5Y Avg)
-20.28
ROA last 12 Months
-56.10
Return on Capital (5Y Avg)
-
ROC last 12 Months
-61.50
Return on invested Capital Q
-8.87
Return on invested Capital Y
-48.20
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.16-14.29Negative
9/2018 FY-1.1718.18Positive
12/2018 QR-0.209.09Positive
9/2019 FY-0.499.26Positive
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume27 408
Shares Outstanding (in ths.)16 200
Trades Count32
Dollar Volume30 038
Avg. Volume91 558
Avg. Weekly Volume46 690
Avg. Monthly Volume30 508
Avg. Quarterly Volume95 731

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

57%43%

Bearish Bullish

48%52%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News